Skip to content

Novel Glycosylated Anti-Tumor Ether Lipid Compounds Target Drug-resistant, Recurrent Ovarian Cancer Cells

We have developed a group of drugs with the unique ability to target cancer stem cells.

Published: 10th June 2020
Novel Glycosylated Anti-Tumor Ether Lipid Compounds Target Drug-resistant, Recurrent Ovarian Cancer Cells
Header image is purely illustrative. Source: SmirkDingo, stock.adobe.com
IP Status
  • Patented
Seeking
  • Development partner
  • Commercial partner
  • Licensing